The FDA has halted U.S. enrollment…
The FDA has halted U.S. enrollment for Newron Pharmaceuticals’ phase [...]
AstraZeneca has announced it will…
AstraZeneca has announced it will resume a £300 million investment [...]
Teva Pharmaceuticals has struck a…
Teva Pharmaceuticals has struck a deal to buy Emalex Biosciences [...]
The FDA has released briefing…
The FDA has released briefing documents detailing its concerns for [...]
The FDA today announced a new…
The FDA today announced a new initiative to allow its [...]
After mulling its options for the…
After mulling its options for the past few months, Protagonist [...]
Both Seaport and Hemab are hoping…
Both Seaport and Hemab are hoping to bring in around [...]
Compass Therapeutics shed half its…
Compass Therapeutics shed half its stock price this morning as [...]
Astellas Pharma has done some…
Astellas Pharma has done some spring cleaning of its pipeline, [...]
The FDA is awarding national…
The FDA is awarding national priority vouchers to Compass Pathways, [...]